{"transactions":[{"id":820198,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests in equal monthly installments over the four year period beginning February 29, 2024. The grant date for the stock option is March 1, 2024. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820197,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests in equal monthly installments over the four year period beginning February 29, 2024. The grant date for the stock option is March 1, 2024. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":75000,"derivative":{"exercise_price":0.615,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820196,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7080,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.5,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820195,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":7080,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option is fully vested."}],"balance_after":7080,"derivative":{"exercise_price":0.615,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":7080},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820194,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.25,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820193,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option is fully vested."}],"balance_after":8000,"derivative":{"exercise_price":0.615,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820192,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024. The grant date for the stock option is October 29, 2024. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.15,"expiration_date":"2034-10-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820191,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024. The grant date for the stock option is October 29, 2024. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":125000,"derivative":{"exercise_price":0.615,"expiration_date":"2034-10-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820190,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is August 25, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":22021},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820189,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":22021,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is August 25, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":22021,"derivative":{"exercise_price":0.615,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":22021},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820188,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9194,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests in equal monthly installments over the four year period beginning August\n24, 2023. The grant date for the stock option is November 6, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2033-11-06","underlying":"Common Stock","underlying_shares":9194},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820187,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":9194,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option was omitted from the Reporting Person's original Form 3, filed on March 4, 2024. The stock option vests in equal monthly installments over the four year period beginning August\n24, 2023. The grant date for the stock option is November 6, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":9194,"derivative":{"exercise_price":0.615,"expiration_date":"2033-11-06","underlying":"Common Stock","underlying_shares":9194},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820186,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in equal monthly installments over the four year period beginning February 21, 2025. The grant date for the stock option is February 25, 2025. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.89,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":820185,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T18:07:48.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in equal monthly installments over the four year period beginning February 21, 2025. The grant date for the stock option is February 25, 2025. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":150000,"derivative":{"exercise_price":0.615,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-26-023340","document":"wk-form4_1775167665.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026023340/wk-form4_1775167665.xml","form_type":"4"}},{"id":914651,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-09T20:54:23.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the four-year period beginning January 19, 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.82,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-26-006620","document":"wk-form4_1770688461.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000162828026006620/wk-form4_1770688461.xml","form_type":"4"}},{"id":1243631,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T17:38:07.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the four year period beginning February 21, 2025."}],"balance_after":150000,"derivative":{"exercise_price":2.89,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001516551-25-000006","document":"wk-form4_1740609481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655125000006/wk-form4_1740609481.xml","form_type":"4"}},{"id":1357539,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-11-20T08:23:53.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":19489,"price":4.99,"value":97250.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade."}],"balance_after":82259,"source":{"system":"sec-edgar","filing":"0001516551-24-000119","document":"wk-form4_1732109026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655124000119/wk-form4_1732109026.xml","form_type":"4"}},{"id":1357538,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-11-20T08:23:53.000Z","date":"2024-11-15","kind":"sale","planned":false,"acquired":false,"shares":85,"price":5.55,"value":471.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."}],"balance_after":101748,"source":{"system":"sec-edgar","filing":"0001516551-24-000119","document":"wk-form4_1732109026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655124000119/wk-form4_1732109026.xml","form_type":"4"}},{"id":1379502,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-30T20:33:12.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024."}],"balance_after":125000,"derivative":{"exercise_price":5.15,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001516551-24-000103","document":"wk-form4_1730334786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655124000103/wk-form4_1730334786.xml","form_type":"4"}},{"id":1603763,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T06:19:07.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the four year period beginning February 29, 2024. Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":75000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001516551-24-000020","document":"wk-form4_1709551139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655124000020/wk-form4_1709551139.xml","form_type":"4"}},{"id":1603762,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":54319,"kind":"person","name":"Diep Tuan Tu","position":1,"cik":"0002013809","reported_name":"Diep Tuan Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2024-03-04T06:19:07.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following milestones: 25% vests upon achieving a market cap of $750M and a stock price of $20.00 per share, an additional 25% vests upon achieving a market cap of $1B and a stock price of $25.00 per share, an additional 25% vests upon achieving a market cap of $1.25B and a stock price of $30.00 per share, an additional 25% vest upon achieving a market cap of $1.5B or greater and a stock price of $35.00 per share; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs. Upon a change in control of the Issuer, 100% of the RSUs will become fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":101833,"source":{"system":"sec-edgar","filing":"0001516551-24-000020","document":"wk-form4_1709551139.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013809/000151655124000020/wk-form4_1709551139.xml","form_type":"4"}}]}